ACE and kidney failure: MYH9-RD patients may benefit from regular urine analysis, since appearance of proteinuria may support the use of therapies such as angiotensin II receptor blockers (ARB-II) and/or angiotensin-converting enzyme inhibitors (ACEI), aiming to prevent or delay kidney failure.